VIDEO: Novel complexity score may improve expectations after retroperitoneal sarcoma surgery
Click Here to Manage Email Alerts
In this video, Chandrajit Raut, MD, MS, discussed results from the first study using a registry trying to “raise the quality of surgery” for retroperitoneal sarcomas, which was presented at the Connective Tissue Oncology Society Annual Meeting.
Raut, chief of surgical oncology at Brigham and Women’s Hospital, surgical director of the Dana-Farber Brigham Cancer Center sarcoma and bone oncology programs, and professor of surgery at Harvard Medical School, said that the registry currently has over 3,000 patients representing about 20 different centers around the world.
The study by the Transatlantic Australasian Retroperitoneal Sarcoma Working Group (TARPSWG), which Raut is a co-founder of, used this prospective registry to develop a complexity score to predict morbidity and mortality after a resection of a retroperitoneal sarcoma.
“[The study] showed that basically — given our understanding of what an operation is going to consist of in the clinic setting before surgery — we can tell a patient this is what to expect, this is your potential risk for a complication, and we have now some accurate prospective data to back up the questions patients have,” he said.
Reference:
- Fairweather M, et al. Paper 78. Presented at: Connective Tissue Oncology Society Annual Meeting; Nov. 1-4, 2023; Dublin.